ODBORNÉ PUBLIKÁCIE (zoznam základných prístupných odborných publikácií zoradených podľa typu analýzy):


  1. Narod, S., A., Foulkes, W., D., 2004: BRCA1 and BRCA2: 1994 and beyond. Nature Rev 4: 665-76. (PubMed)
  2. Vasickova, P., Machackova, E., Lukesova, M., Damborsky, J., Horky, O., Pavlu, H., Kuklova, J., Kosinova, V., Navratilova, M., Foretova, L., 2007: High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet 8:32.(PubMed)
  3. Welcsh, P., L., Owens, K., N., King, M., C., 2000: Insights into the functions of BRCA1 and BRCA2. Trends Genet 16(2): 69-74.(PubMed)
  4. Wagner T.M.U., Hirtenlehner K., Shen P., el all: Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwilde populatins. Hum. Mol. Genetocs, Vol. 8, No. 3, 1999.(PubMed)


  1. Laud K, Marian C, Avril MF, Barrois M, Chompret A, Goldstein AM, Tucker MA, Clark PA, Peters G, Chaudru V, Demenais F, Spatz A, Smith MW, Lenoir GM, Bressac-de Paillerets B; French Hereditary Melanoma Study Group: Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of malanoma. J Med Genet. Jan;43(1):39-47. 2006. (PubMed)
  2. Fowler ES, Wolf KS, Chesney TMcC, Schwartzberg LS: Genetic testing for hereditary mealnoma: Controversial, standard of care, or somewhere between the two? Community Oncology March 3:158-161. 2006.(Link)
  3. Goldstein AM: Familial Melanoma, Pancreatic Cancer and Germline CDKN2A Mutations.. Human Mutation. 718. 2004. (PubMed)


  1. De Groot JW, Links TP, Plukker JTM, Lips CJM, Hofstra RMW: RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocrine Reviews 27(5):535-560. 2006. (PubMed)
  2. Baumgartner-Parzer SM. Lang R, Wagner L, Heinze G, Niederle B, Kaserer K, Waldhausl W, Vierhapper H: Polymorphisms in exon 13 and intron 14 of RET protooncogene: Genetic modifiers of medullary thyroid carcinoma? J Clin Endocrinol Metab 90(11):6232-6236. 2005. (PubMed)


  1. Benvenuti S, Sartore-Bianchi A, di Nicolantonio F, Zanon C, Moroni M, Veronese S, Siena S, Bardelli A: Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies. Cancer Res 67(6):2643-2648. 2007. (PubMed)
  2. Van Krieken JHJM, Jung A, Kirchner T et al.: KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. Virchows Arch 453:417-431. 2008. (PubMed)


  1. Nikiforov YE: thyroid carcinoma: molecular pathways and therapeutic targets. Modern pathology 21:S37-S43. 2008. (PubMed)
  2. Elisei R, Ugolini C, Viola D, Lupi C et al: BRAF V600E mutation and outcome of patients with papillary thyroid carcinoma: A 15-year median follow-up study. J Clin endocrine Metab 93(10):3943-3949. 2008. (PubMed)

HPV genotyp:

  1. Meijer CHJ, Snijders PJ, Castle PE: Clinical utility of HPV genotyping. Gynecologic Oncology 103: 12-17. 2006. (PubMed)
  2. Barzon L, Giorgi C, Buonaguro FM, Palú G: Guidelines of the Italian Society for Virology on HPV testing and vaccination for cervical cancer prevention. Infectious Agents and Cancer 3:14 doi:10.1186/1750-9378-3-142008, 2008. (PubMed)

HPV expresia:

  1. Weismann P, Weismanova E, Masak L a kol.: The detection of circulating tumor cells expressing E6/E7 HR-HPV oncogenes in peripheral blood in cervical cancer patients. NEOPLASMA 2009, 56(3);230-238. (PubMed)
  2. Cuschieri K, Wentzensen N: Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia. Cancer Epidemiol Biomarkers Prev. 17(10):2536-45, 2008. (PubMed)


  1. Liu Y, Peng H, Zhang J-T: Expression profiling of ABC transporters in a drug-resistant breast cancer cell line using AmpArray. Mol Pharmacol 68(2):430-438, 2005. (PubMed)
  2. Gillet JP, Gottesman MM: Mechanisms of Multidrug Resistance in Cancer in Multi-Drug Resistance in Cancer, Methods in Molecular Biology, vol. 596, Humana Press, a part of Springer Science + Business Media, LLC 2010. (PubMed))